Us FDA Approves Lasers for Eye Surgery

Lumenis receives clearance from the US Food and Drug Administration (FDA) to start selling three of its ophthalmic laser systems. The approved devices treat a range of eye conditions including age-related macular degeneration, glaucoma and secondary cataracts. According to Robert Grant, an executive vice-president at Lumenis, the company submitted its applications to the FDA so that any approvals would coincide with the American Academy of Ophthalmology meeting currently happening in Orlando, US.

"It takes about 90 days for the FDA to turn round a submission, so we timed our applications" he told Optics.org. "We hoped that at least two of the three devices would receive clearance." The systems now sealed with the FDA's approval are the Novus Varia, the Selecta Duet and the Novus Spectra. Lumenis says its Novus Varia photocoagulator is the first solid-state multi-wavelength ophthalmic laser of its kind. Based on a diode-pumped semiconductor laser, the single device can emit green, yellow or red beams.

(Source: APBiscom)